Intellia Therapeutics (NTLA) added ~15% in the premarket on Tuesday after the U.S. Food and Drug Administration lifted a ...
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its fourth-quarter 2025 investor letter for the “Baird Chautauqua International and ...
Among other things, we talked about President Trump’s “most-favored nations” policy on drug pricing and why Regeneron is the ...
Jericho High School senior Ashka Shah was named the lone finalist in Nassau County for the Regeneron Science Talent Search, ...
Plotting a challenge to Regeneron’s blockbuster Eylea, Ocular Therapeutix has hired “a key architect” of its rival’s launch ...
Regeneron Pharmaceuticals has recently drawn renewed attention as investment funds, Wall Street analysts, and industry ...
Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...
The Regeneron Science Talent Search 2026 finalists represent 35 schools across 15 states. They are competing for more than $1.8 million, with a top prize of $250,000 to further their scientific ...
Regeneron's strategy focuses on a broad pipeline across six therapeutic areas, with significant near-term data readouts ...
Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...
Ashka Shah, a senior at Jericho High School, was one of 40 winners announced Wednesday by the Washington, D.C.-based ...
On Wednesday, January 21, the Society for Science (the Society) and Regeneron announced the top 40 finalists in the Regeneron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results